Toni Choueiri
MD
Director, Lank Center for Genitourinary Oncology
👥Biography 个人简介
Toni Choueiri is widely regarded as the most influential clinical researcher in advanced renal cell carcinoma globally. He has led or co-led most of the landmark RCC trials that changed the standard of care over the past two decades, including CheckMate-9ER and the CLEAR trial. His research on belzutifan and HIF-2alpha pathway inhibition in VHL disease and RCC opened a new class of targeted agents. He leads the IMDC prognostic tool widely used in RCC.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Toni Choueiri 的研究动态
Follow Toni Choueiri's research updates
留下邮箱，当我们发布与 Toni Choueiri（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment